VOR earnings: real EPS beat/miss history, analyst consensus Buy, P/E -0.03. Updated 2026-07-23.
Vor Biopharma (VOR) Research Hub
Vor Biopharma (VOR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 22.3 USD (-4.04%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.03, market cap 0.13B. This hub links to the full technical, earnings and options research available for VOR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 22.3 USD (-4.04%) |
| 52-week range | 13.45 USD – 26 USD |
| Trend regime | Range |
| 14-day RSI | 42.2 (Bearish) |
| Trailing P/E | -0.03 |
| Market cap | 0.13B |
| Dividend yield | 0.00% |
Available research for VOR
Covered Call on VOR: how it works, illustrative setup around the real 22.3 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on VOR: how it works, illustrative setup around the real 22.3 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on VOR: how it works, illustrative setup around the real 22.3 USD price, max profit/loss, breakeven and when to use it. Educational.
VOR technical analysis: range, last 22.3 USD, RSI 42.2, 52w range 13.45 USD–26 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is VOR in?
Vor Biopharma (VOR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is VOR in an uptrend or downtrend?
As of 2026-09-11, VOR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is VOR's trailing P/E ratio?
VOR's trailing P/E is -0.03, with a market cap of 0.13B. See the earnings research page for full valuation detail.